162 related articles for article (PubMed ID: 22791812)
21. Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer.
Zhang L; Zhou F; ten Dijke P
Trends Biochem Sci; 2013 Dec; 38(12):612-20. PubMed ID: 24239264
[TBL] [Abstract][Full Text] [Related]
22. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.
Mao XG; Hütt-Cabezas M; Orr BA; Weingart M; Taylor I; Rajan AK; Odia Y; Kahlert U; Maciaczyk J; Nikkhah G; Eberhart CG; Raabe EH
Oncotarget; 2013 Jul; 4(7):1050-64. PubMed ID: 23846349
[TBL] [Abstract][Full Text] [Related]
23. The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation.
Shi JW; Liu W; Zhang TT; Wang SC; Lin XL; Li J; Jia JS; Sheng HF; Yao ZF; Zhao WT; Zhao ZL; Xie RY; Yang S; Gao F; Fan QR; Zhang MY; Yue M; Yuan J; Gu WW; Yao KT; Xiao D
Cell Cycle; 2013 Apr; 12(7):1119-27. PubMed ID: 23466707
[TBL] [Abstract][Full Text] [Related]
24. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
25. TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases.
Al-Azayzih A; Gao F; Goc A; Somanath PR
Biochem Biophys Res Commun; 2012 Oct; 427(1):165-70. PubMed ID: 22989755
[TBL] [Abstract][Full Text] [Related]
26. MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor.
Wang Y; Guo Z; Tian Y; Cong L; Zheng Y; Wu Z; Shan G; Xia Y; Zhu Y; Li X; Song Y
BMC Cancer; 2023 Oct; 23(1):959. PubMed ID: 37817112
[TBL] [Abstract][Full Text] [Related]
27. Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications.
Luo J; Li Y; Zhang T; Xv T; Chen C; Li M; Qiu Q; Song Y; Wan S
Front Oncol; 2022; 12():1092705. PubMed ID: 36793345
[TBL] [Abstract][Full Text] [Related]
28. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
29. The contributions of extrachromosomal DNA elements in neoplasm progression.
Hong J; Zheng S; Jiang D
Am J Cancer Res; 2021; 11(6):2417-2429. PubMed ID: 34249408
[TBL] [Abstract][Full Text] [Related]
30. The role of S100A4 for bone metastasis in prostate cancer cells.
Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
[TBL] [Abstract][Full Text] [Related]
31. Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1.
Wang B; Yan S; Yi Y; Huang Y; Deng Z; Zhang Y; Zheng Q; Xie H; Li J
Front Cell Dev Biol; 2020; 8():691. PubMed ID: 32850814
[TBL] [Abstract][Full Text] [Related]
32. BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer.
Shafran JS; Jafari N; Casey AN; Győrffy B; Denis GV
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):268-277. PubMed ID: 32690869
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond.
Tam SY; Wu VWC; Law HKW
Front Oncol; 2020; 10():486. PubMed ID: 32322559
[TBL] [Abstract][Full Text] [Related]
34. S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.
Nader JS; Guillon J; Petit C; Boissard A; Franconi F; Blandin S; Lambot S; Grégoire M; Verrièle V; Nawrocki-Raby B; Birembaut P; Coqueret O; Guette C; Pouliquen DL
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290283
[TBL] [Abstract][Full Text] [Related]
35. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
Chen Y; Liu P; Shen D; Liu H; Xu L; Wang J; Shen D; Sun H; Wu H
Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988090
[TBL] [Abstract][Full Text] [Related]
36. Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.
Sheng W; Shi X; Lin Y; Tang J; Jia C; Cao R; Sun J; Wang G; Zhou L; Dong M
J Exp Clin Cancer Res; 2020 Jan; 39(1):16. PubMed ID: 31952541
[TBL] [Abstract][Full Text] [Related]
37. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X; Qu P; Zhao H; Zhao T; Cao N
Mol Med Rep; 2019 Oct; 20(4):3811-3819. PubMed ID: 31485669
[TBL] [Abstract][Full Text] [Related]
38. Encircling the regions of the pharmacogenomic landscape that determine drug response.
Fernández-Torras A; Duran-Frigola M; Aloy P
Genome Med; 2019 Mar; 11(1):17. PubMed ID: 30914058
[TBL] [Abstract][Full Text] [Related]
39. Intracellular and extracellular TGF-β signaling in cancer: some recent topics.
Miyazono K; Katsuno Y; Koinuma D; Ehata S; Morikawa M
Front Med; 2018 Aug; 12(4):387-411. PubMed ID: 30043220
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.
Hu B; Jin X; Wang J
Oncol Res; 2018 Aug; 26(7):1093-1102. PubMed ID: 29321092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
